CAPTRUST FINANCIAL ADVISORS - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$7,000
-41.7%
2,783
-7.2%
0.00%
Q2 2021$12,000
-14.3%
2,999
-3.4%
0.00%
Q1 2021$14,0003,1050.00%
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders